European Innovation Council selects ISAR Bioscience project for breakthrough technology in receptor research
The European Innovation Council (EIC) has announced the selection of proposals from the 2023 EIC Pathfinder Open call, which funds ideas for new breakthrough technologies. The UniSens consortium, organized by ISAR Bioscience, is among the 53 projects from all over Europe and from a wide range of fields - health, artificial intelligence, computing, environment and energy. Our application was selected from among 783 submissions and is one of the few led by a small or medium-sized enterprise (SME).
The UniSens consortium includes academic and SME partners from the Czech Republic, France, the Netherlands, Spain, Switzerland and Germany. It aims to develop a completely new technology for the discovery of drugs that act on receptors - the largest and most important group of therapeutic drugs. “I am thrilled that the evaluators in Brussels recognized the enormous potential of our cutting-edge technology inspired by our scientific discoveries,” said Dr. Martha Sommer, head of the receptor team at ISAR Bioscience and coordinator of the UniSens consortium. “We will now enter into negotiations with the EU to finalize our grant agreement,” adds Professor Martin Lohse, Chairman of ISAR Bioscience. Funding for the four-year project is expected to be well over €3 million.